Inecalcitol, an analog of 1,25D₃, displays enhanced antitumor activity through the induction of apoptosis in a squamous cell carcinoma model system
Transcription, Genetic
Antineoplastic Agents
Apoptosis
X-Linked Inhibitor of Apoptosis Protein
Cell Cycle Checkpoints
Inhibitor of Apoptosis Proteins
3. Good health
Enzyme Activation
Disease Models, Animal
Mice
03 medical and health sciences
0302 clinical medicine
Alkynes
Caspases
Cell Line, Tumor
Carcinoma, Squamous Cell
Animals
Drug Screening Assays, Antitumor
Vitamin D
Cell Proliferation
Cholecalciferol
DOI:
10.4161/cc.23846
Publication Date:
2013-02-22T10:37:03Z
AUTHORS (7)
ABSTRACT
Epidemiological data suggest an important role of vitamin D signaling in cancer development and progression, experimental studies demonstrate that the active metabolite 1α, 25-dihydroxyvitamin D₃ (1,25D₃) has broad spectrum antitumor activity. Hypercalcemia often been suggested to limit clinical application these data. The 14-epi-analog 1,25D₃, inecalcitol [19-nor-14-epi-23-yne-1,25-(OH)₂D₃; TX522], was developed have superagonistic activities but low hypercalcemia potential. We examined activity underlying mechanisms a murine squamous cell carcinoma (SCC) model system. In vitro, compared with showed enhanced receptor (VDR)-mediated transcriptional Inecalcitol suppressed SCC proliferation dose-dependent manner IC50 value 30 times lower than 1,25D₃. Both 1,25D₃ induced comparable level G0/G₁ cycle arrest cells. apoptosis by markedly higher Apoptosis mediated through activation caspase 8/10- 3 pathway. Further, inhibited mRNA protein expression c-IAP1 XIAP vivo, inhibits tumor growth fashion. Notably, significantly xenograft model. While vitro demonstrates apparent VDR binding antiproliferative effects vivo advantages disappear; at doses equivalent effects, similar is seen. This may be explained pharmacokinetics vs. attributed much shorter serum half-life inecalcitol.We show potent system, this associated strong induction apoptosis. These findings support further treatment.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (29)
CITATIONS (35)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....